Advertisement
Advertisement

RZLT

RZLT logo

Rezolute, Inc. Common Stock (NV)

3.33
USD
Sponsored
+0.08
+2.58%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

3.35

+0.01
+0.33%

RZLT Earnings Reports

Positive Surprise Ratio

RZLT beat 17 of 26 last estimates.

65%

Next Report

Date of Next Report
Feb 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.19
Implied change from Q1 26 (Revenue/ EPS)
--
/
+5.56%
Implied change from Q2 25 (Revenue/ EPS)
--
/
-13.64%

Rezolute, Inc. Common Stock (NV) earnings per share and revenue

On Nov 06, 2025, RZLT reported earnings of -0.18 USD per share (EPS) for Q1 26, beating the estimate of -0.27 USD, resulting in a 33.41% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +12.08% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 12 analysts forecast an EPS of -0.19 USD, with revenue projected to reach -- USD, implying an increase of 5.56% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q1 2026, Rezolute, Inc. Common Stock (NV) reported EPS of -$0.18, beating estimates by 33.41%, and revenue of $0.00, 0% as expectations.
The stock price moved up 12.08%, changed from $9.60 before the earnings release to $10.76 the day after.
The next earning report is scheduled for Feb 10, 2026.
Based on 12 analysts, Rezolute, Inc. Common Stock (NV) is expected to report EPS of -$0.19 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement